Vontur 2005.

Trial name or title	NCT00223418
Methods	Allocation: random. Blindness: open label. Duration: unspecified. Design: parallel.
Participants	Diagnosis: schizophrenia. Age 18‐52 years. Gender: male and female participants. History: duration of illness not reported. Setting: not specified.
Interventions	1. Aripiprazole. 2. Olanzapine.
Outcomes	Improvement in cognitive functions, long‐time effectiveness and tolerability, social and occupational functioning.
Starting date	September 2005.
Contact information	United States of America.
Notes

Global rating scales
 CGI: Clinical Global Impressions
 PGI‐I: Patient’s Global Impressions of Improvement
 
 Mental state:
 MADRS: Montgomery‐Asberg Depression Rating Scale
 PANSS: Positive and Negative Syndrome Scale

Depression:
 MADRS: Montgomery–Åsberg Depression Rating Scale

Sexual functioning: 
 GISF: Global Impressions of Sexual Function

Side effects:
 AIMS: Abnormal Involuntary Movement Scale
 BAS: Barnes Akathisia Scale
 SAS: Simpson‐Angus Index ‐ for neurological side effects

Quality of Life: 
 IWQoL‐Lite: Impact of Wieght on Quality of Life
 SF‐36: Short form 36
 SWN‐S: subjective well‐being
 
 Other
 BMI: body mass index
 EPS: extrapyramidal symptoms
 HDL:high‐density lipoprotein
 MOS: Medical Outcomes Study
 MRI: magnetic resonance imaging
 PET: positron emission tomography